Gary Dykstra, director of Biomedical Continuing Education and Strategic Planning in the College of Pharmacy and a former Food and Drug Administration official, was quoted in several New York Times articles about the meningitis outbreak reportedly stemming from a large-scale compounding pharmacy in Massachusetts.
Dykstra explained past difficulties in regulating these facilities.
“They were pushing the limits of pharmacy practice,” said Dykstra of his regulation experience with the facilities in the 1990s. “We were seeing some very clever entrepreneurs that were trying to get a foothold in what they saw as a need but taking it to extremes.”
